Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2019

01-11-2019 | Breast Cancer | Correction

Correction to: Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts

Authors: Yangyang Bu, Jun Xia, Bobby Joseph, Xianjing Zhao, Maosheng Xu, Yingxing Yu, Shouliang Qi, Kamran A. Shah, Shiwei Wang, Jiani Hu

Published in: Breast Cancer Research and Treatment | Issue 1/2019

Login to get access

Excerpt

In the original version of the article, the image of Fig. 2 was erroneously duplicated as Fig. 4. The correct version of Fig. 4 is given below. The original article has been corrected.
Metadata
Title
Correction to: Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts
Authors
Yangyang Bu
Jun Xia
Bobby Joseph
Xianjing Zhao
Maosheng Xu
Yingxing Yu
Shouliang Qi
Kamran A. Shah
Shiwei Wang
Jiani Hu
Publication date
01-11-2019
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05383-w

Other articles of this Issue 1/2019

Breast Cancer Research and Treatment 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine